T0	Participants 16 31	unstable angina
T1	Participants 133 149	unstable angina.
T2	Participants 156 164	patients
T3	Participants 446 619	The study population included 403 of the original 479 patients in the trial who had completed six days of blinded therapy without refractory angina or myocardial infarction.